Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-ranging study of UNR844 eye drops in presbyopia
jRCT2051210054Completed
- Sponsor
- Novartis
- Start
- Aug 2021
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of lipoic acid choline ester in presbyopia (5 arms), sponsored by Novartis. Primary endpoint: Change from baseline in binocular distance-corrected near visual acuity (letters) at Month 3. Started Aug 2021; status: completed.
02
Drugs
lipoic acid choline ester
03
Conditions
presbyopia
Beyond the preview
Go deeper on jRCT2051210054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2051210054.